MinorPrimary completion pushed from Sep 1, 2026 to Nov 1, 2026
Study completion pushed from Sep 1, 2026 to Dec 1, 2026
Eligibility criteria expanded, about 17 words
Secondary endpoints: 6 to 5
Minor2 versionsRe-verified since Oct 6, 2025, no change to tracked fieldsv5-v6
MinorPrimary completion date: Jul 1, 2026 to Sep 1, 2026
Study completion date: Jul 1, 2027 to Sep 1, 2026
v4
MinorEligibility criteria revisedv3
NotablePhase: Phase 2 to Not applicablev2Show 4 more changesShow less
Trial status: Not Yet Recruiting to Recruiting
Study sites: 0 to 1
Interventions: Sham tDCS and Mindfulness (Device), transcranial direct current stimulation (tDCS) (Device) to Sham tDCS and Mindfulness (Device), transcranial direct current stimulation (tDCS) and mindfulness instruction (Device)
Secondary endpoints: 9 to 6
MinorStudy First Submitted
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.